var path='https://www.tickertech.net';
function heading(heading) {
document.write('<p><table border="0" cellspacing="0" cellpadding="0" width="100%">'+
'<tr><td><span class="heading">&#149; '+heading+'</span></td></tr>'+
'<tr height="1" bgcolor="#EFEFEF"><td height="1">'+
'<img src="'+path+'/pics/tpixel.gif" width="1" height="1">'+
'</td></tr></table><p>');
}
function hiLite(imgDocID,imgObjName) {
document.images[imgDocID].src = eval(imgObjName + ".src");	
}
function showStatus(toshow) {
window.status = toshow;
}
function checkChoose() {
if (document.choose.ticker.value == "") {
alert("Please enter symbols before clicking the go button");
return false;
}
else return true;
}
function popJT(url,name){
var xwid = screen.width;
xwid = xwid - 10;
javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no');
javaticker.opener.name="opener";
//javaticker.moveTo(0,30);
}



	var allow = 0;
	var ref = ""+location;
	if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; }
	
function ShowTTIPage() {
if (allow) { document.write('<STYLE TYPE="text/css">\n'); }
if (allow) { document.write('<!-- \n'); }
if (allow) { document.write('.TTIptext, .TTIptext SELECT, .TTIptext INPUT {\n'); }
if (allow) { document.write('font-family: Arial,Helvetica,Times\;\n'); }
if (allow) { document.write('font-size:9pt\;\n'); }
if (allow) { document.write('color: #000000 \n'); }
if (allow) { document.write('}\n'); }
if (allow) { document.write('.menu {\n'); }
if (allow) { document.write('font-family: Arial,Helvetica,Times\;\n'); }
if (allow) { document.write('font-size:10pt\;\n'); }
if (allow) { document.write('color: #000000 \n'); }
if (allow) { document.write('}\n'); }
if (allow) { document.write('.menubld {\n'); }
if (allow) { document.write('font-family: Arial,Helvetica,Times\;\n'); }
if (allow) { document.write('font-size:10pt\;\n'); }
if (allow) { document.write('font-weight: bold\;\n'); }
if (allow) { document.write('color: #000000 \n'); }
if (allow) { document.write('}\n'); }
if (allow) { document.write('.heading {\n'); }
if (allow) { document.write('font-family: Arial,Helvetica,Times\;\n'); }
if (allow) { document.write('font-size: 12pt\;\n'); }
if (allow) { document.write('font-weight: bold\;\n'); }
if (allow) { document.write('font-color: black\;\n'); }
if (allow) { document.write('}\n'); }
if (allow) { document.write('a{text-decoration: underline}\n'); }
if (allow) { document.write('a.TTIplink:link{color:#222222}\n'); }
if (allow) { document.write('a.TTIplink:visited{color:#222222}\n'); }
if (allow) { document.write('a.TTIplink:active, a.TTIplink:hover{color:#555555}\n'); }
if (allow) { document.write('a.white:link, a.white:visited{color:#ffffff}\n'); }
if (allow) { document.write('a.white:active, a.white:hover{color:#dddddd}\n'); }
if (allow) { document.write('a.red:link, a.red:visited{color:#a50000}\n'); }
if (allow) { document.write('a.red:active, a.red:hover{color:#ff0000}\n'); }
if (allow) { document.write('-->\n'); }
if (allow) { document.write('</STYLE>\n'); }
if (allow) { document.write('<div name="ptnews" id="ptnews" style="width: 420px"></div>\n'); }
if (allow) { document.write('<table border="0" cellspacing="0" cellpadding="2" width="420">\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">4/10 - 6:01 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.etfchannel.com/quotes/?a=news&ticker=a&w=&story=202404202404100600PR_NEWS_USPR_____SF84197" class="TTIplink">Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine\'s Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">2/26 - 4:06 PM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.etfchannel.com/quotes/?a=news&ticker=a&w=&story=202402202402261605PR_NEWS_USPR_____SF44967" class="TTIplink">Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">2/22 - 6:01 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.etfchannel.com/quotes/?a=news&ticker=a&w=&story=202402202402220600PR_NEWS_USPR_____SF42892" class="TTIplink">Theravance Biopharma to Participate in an Upcoming Investor Conference</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">2/14 - 6:01 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.etfchannel.com/quotes/?a=news&ticker=a&w=&story=202402202402140600PR_NEWS_USPR_____SF36395" class="TTIplink">Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">1/5 - 6:01 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.etfchannel.com/quotes/?a=news&ticker=a&w=&story=202401202401050600PR_NEWS_USPR_____SF04975" class="TTIplink">Theravance Biopharma Announces Results from the Phase 4 YUPELRI&#x00AE\; PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr height="3"><td height="3"><img src="https://www.tickertech.net/pics/tpixel.gif" width="1" height="3" alt=""></td></tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td colspan="2"></td></form>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('</table>\n'); }
if (!allow) { document.write(''+ ''+
'	<h1>Access Denied</h1>'+
'	<h2><font color=red>Please Read This Important Message</font></h2>'+
'	If you are a paying TickerTech.com client and your account was not set up to include the configuration'+
'	received, please email <a href="mailto:support@tickertech.com" class="meta">support@tickertech.com</a>,'+
'	or call us at 1-866-515-2082 to verify your account settings.'+
'	'+
'	<br><br>'+
'	'+
'	<img src="https://www.tickertech.net/pics/caution.gif" width=16 height=16 alt="Note!"> If you reached this page'+
'	after attempting to place a TickerTech.com product onto your web page, go no further;  you must sign up as a'+
'	paying client.  For pricing information please visit our <a href="http://www.tickertech.com/products/">products page</a>, email '+
' 	<a href="mailto:services@tickertech.com">services@tickertech.com</a>, or give us a call at 1-866-515-2082.'+
' 	'+
' 	<br><br>'+
' 	'+
' 	<a href="http://www.tickertech.com/" class="meta">TickerTech.com home</a><br>'+
' 	<a href="http://www.tickertech.com/products/" class="meta">TickerTech.com products</a>'+
' 	<BR>'+
' 	'+
''); }

}